Nocturne Acquisition Corp. (MBTC) to Combine with Cognos Therapeutics in $120M Deal

Nocturne Acquisition Corp. (NASDAQ:MBTC) has entered into a definitive agreement to combine with medical technology company Cognos Therapeutics at an enterprise value of $120 million. Inglewood, California-based Cognos Therapeutics is a medical device company that develops diagnostic and drug delivery devices designed to detect diseases. The parties expect to close the deal in the second or third
Read More